Hybrid closed-loop insulin therapy prevents low night-time blood glucose levels among breastfeeding mothers with type 1 ...

Early morning hyperglycemia is sometimes called the “dawn phenomenon.” Left untreated, it can drive poorer outcomes. How can ...

“These results support the continued investigation of intranasal insulin and empagliflozin combination therapy for AD,” they ...

Type 1 diabetes in China has successfully undergone a stem-cell therapy that enabled her to produce her own insulin, reducing ...

Early research shows the CD40L antibody tegoprubart is able to reduce insulin dependence in patients with type 1 diabetes after islet transplants.

This hindrance in leptin delivery poses a challenge to using this adipokine as a potential therapy for obesity ... to ...

A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the ...

At a meeting of the Food and Drug Administration’s (FDA) Endocrinologic and Metabolic Drugs Advisory Committee, the majority of panel members voted against the approval of sotagliflozin (Zynquista™) ...

Insulin is crucial for helping the body convert glucose into ... According to research from the Journal of the American ...

Just 75 days after the transplant, the patient no longer needed insulin injections. The breakthrough, published in the ...

Q3 2024 Earnings Call Transcript November 6, 2024 Tandem Diabetes Care, Inc. beats earnings expectations. Reported EPS is $-0 ...